A healthcare-services business is usually valued as a multiple of its adjusted EBITDA, and across most subsectors the buyer pool is led by private-equity-backed platforms pursuing consolidation, or "roll-up," strategies. Investors are drawn to healthcare for the same reasons owners find it demanding: demand is durable and largely non-discretionary, revenue often recurs through repeat visits and payor relationships, and a fragmented market of independent practices creates room to combine many small operators into one larger, more valuable platform. That combination is why well-run practices, agencies, and clinics can command meaningful multiples when they are prepared and taken to market properly.
Selling a healthcare business, though, is more involved than selling a comparable-sized company in most other industries. Buyers underwrite payor mix, provider retention, and regulatory compliance as closely as they underwrite earnings, and the legal structure of the deal itself is shaped by rules that do not apply outside healthcare. This guide covers how these businesses are valued, who buys them, how to prepare, and what the process realistically looks like.
How healthcare-services businesses are valued
The dominant method in the lower middle market is the adjusted EBITDA multiple. A buyer normalizes your earnings, removing one-time costs, above-market owner compensation, and personal expenses run through the business, then applies a multiple drawn from comparable transactions in your specific subsector. Very small, single-provider practices are sometimes valued on seller's discretionary earnings (SDE) instead, but once a business runs on a management team and multiple providers, EBITDA becomes the standard basis.
Multiples vary widely by subsector because buyers pay for different risk and growth profiles. The table below shows general educational ranges for adjusted EBITDA multiples in the lower middle market. Larger platforms with scale and clean compliance tend toward the top of each range or beyond; small, owner-dependent practices tend toward the bottom.
| Subsector | General EBITDA multiple range |
|---|---|
| Physician / medical practices (single specialty) | 4x - 8x |
| Dental practices and DSOs | 5x - 9x |
| Home health and hospice | 6x - 11x |
| Behavioral health (mental health, SUD, autism/ABA) | 6x - 12x |
| Veterinary practices and groups | 7x - 12x |
| Med-spa and aesthetics | 4x - 8x |
| Healthcare IT and tech-enabled services | 8x - 15x+ |
These ranges are general educational estimates, not an appraisal or a guarantee of value. Actual multiples depend on diligence findings, deal structure, and market conditions at the time of sale, and an individual business can fall well outside its subsector range in either direction.
What drives the multiple up or down
Within any subsector, the same handful of factors separate a top-of-range outcome from a discounted one:
- Payor mix. A diversified mix, and generally a higher share of commercial or private-pay revenue relative to lower-reimbursement government payors, supports a stronger multiple. Heavy concentration in a single payor or program is treated as risk.
- Provider retention. Buyers pay for earnings that survive the transaction. Physicians, dentists, and clinicians locked in under post-close employment or equity-rollover arrangements make earnings far more transferable than a business built around a departing owner.
- De novo and organic growth. A demonstrated ability to open new locations and grow same-store volumes signals a platform the buyer can scale, not just a static book of business.
- Compliance posture. Clean billing, documented coding practices, current licensure and credentialing, and no unresolved regulatory issues reduce perceived risk and protect the price through diligence.
- Scale. Larger EBITDA earns a higher multiple for the same subsector, because bigger, multi-site businesses are more stable and attract better-capitalized buyers. Crossing into true platform scale is often the single biggest re-rating event.
- Recurring and repeat revenue. Ongoing care relationships, recurring treatment plans, membership models, and predictable referral patterns are worth more than one-off episodic volume.
Who buys healthcare-services businesses
Understanding the buyer universe helps you position the business for the group most likely to pay a premium.
- Private-equity platforms and roll-ups. The most active buyers in most subsectors. A PE firm backs an initial platform company, then acquires additional practices ("add-ons") to build regional or national scale. Add-ons are often bought at lower multiples than the platform, and the combined entity is later sold or recapitalized at a higher one.
- Strategic acquirers. Larger operators, health systems, and industry consolidators that buy to expand geography, add specialties, or capture referral volume. Strategics can pay up for a business that fits a specific gap in their footprint.
- Management services organizations (MSOs). Many healthcare deals are structured through an MSO, which acquires and operates the non-clinical assets and administrative functions of a practice, while the clinical entity remains owned by licensed providers. This structure is common precisely because of the regulatory rules described below.
A high-level note on regulation
Healthcare M&A is shaped by rules that most other industries do not face. In many states, corporate practice of medicine (CPOM) doctrines restrict non-physicians (including PE firms and corporate entities) from owning a medical practice or controlling clinical decisions. This is a primary reason deals are frequently structured through an MSO or "friendly PC" model, which separates the clinical entity from the management company. Fraud-and-abuse rules, anti-kickback and self-referral laws, HIPAA, licensure, and payor-enrollment requirements also bear directly on how a transaction can be structured and closed. These points are general background only and are not legal advice. The specific rules vary by state and subsector and change over time, so engage qualified healthcare counsel early to structure any sale.
How to prepare before going to market
Preparation is where healthcare sellers protect the most value, because buyers in this sector diligence deeply and reprice on what they find. Before launching a process, get the following in order:
- Quality of earnings (QoE) and clean financials. A sell-side QoE analysis normalizes your EBITDA into defensible, documented adjusted earnings and surfaces issues before a buyer does. Because the multiple amplifies every dollar of EBITDA, a well-supported add-back can be worth several times its face value at close.
- Provider agreements and retention. Have current, enforceable employment, non-compete (where permitted), and compensation arrangements in place, and think through how key providers will be retained post-close. Provider continuity is often the buyer's single biggest concern.
- Compliance readiness. Organize licensure, credentialing, billing and coding documentation, and any past audits or corrective actions. A coding or billing review before diligence lets you fix problems on your own terms rather than under buyer pressure.
- Payor contracts. Assemble your payor agreements, reimbursement rates, and enrollment status, and confirm which contracts are assignable or require re-credentialing on a change of ownership.
- Financial and corporate diligence file (FDD). Buyers will request several years of financials, tax returns, corporate records, leases, and key contracts. Having a complete, organized data room ready shortens the timeline and signals a well-run business.
The sale process and a realistic timeline
A prepared sell-side process generally follows the same arc, whether run by an advisor, a broker, or a platform:
- Preparation and QoE (roughly 4 to 8 weeks). Normalize earnings, assemble the data room, and produce marketing materials, typically a teaser and a confidential information memorandum.
- Buyer outreach (about 3 to 6 weeks). Approach a targeted set of PE platforms and strategics under NDA, then share the full materials with interested parties.
- Indications of interest and management meetings (about 3 to 5 weeks). Collect preliminary offers, meet the strongest buyers, and narrow the field.
- Letter of intent (LOI). Select a lead buyer and agree headline price and structure, often including cash at close plus rollover equity or an earnout.
- Diligence and legal documentation (roughly 8 to 16 weeks). The buyer conducts financial, quality-of-care, billing, and legal diligence while definitive agreements and, where relevant, MSO structuring are negotiated.
- Signing and closing. Final consents, licensure and payor considerations, and funding.
End to end, a typical lower-middle-market healthcare sale runs roughly six to twelve months, and regulatory or payor consents can extend it. The single biggest driver of a shorter, cleaner process is preparation done before buyers ever see the business.
Starting a prepared process
The owners who achieve the strongest outcomes treat a sale as a prepared process, not an opportunistic response to an inbound offer. That means normalized earnings you can defend, a complete diligence file, provider retention addressed in advance, and a competitive set of qualified buyers rather than a single unsolicited bidder.
As one option in this space, Bankerly.ai runs sell-side M&A processes for lower-middle-market companies, producing quality-of-earnings analysis, valuation, and marketing deliverables alongside buyer outreach. Whatever route you choose, engage healthcare counsel and a tax advisor early, and go to market with the business prepared so that diligence confirms your value rather than eroding it.
A note on the figures above: the multiples shown are general educational estimates, not a formal appraisal or a guarantee of price, and nothing here is legal, tax, or investment advice. Any real number for your business depends on diligence, structure, and market conditions and should be confirmed with your own qualified advisors before you make decisions.
Frequently asked questions
- How are healthcare-services businesses valued?
- Most are valued as a multiple of adjusted EBITDA, meaning normalized earnings after removing one-time costs and above-market owner pay. The multiple is drawn from comparable transactions in your specific subsector and moves with payor mix, provider retention, growth, compliance, and scale. Very small single-provider practices are sometimes valued on seller's discretionary earnings instead.
- What EBITDA multiple does a medical or dental practice sell for?
- As a general educational range, single-specialty physician practices often trade around 4x to 8x adjusted EBITDA, and dental practices or DSOs around 5x to 9x. Larger, multi-site, compliant platforms tend toward or above the top of these ranges. These are orientation figures, not a quote; an individual practice can fall outside them depending on diligence and structure.
- Who buys healthcare-services businesses?
- The most active buyers are private-equity-backed platforms building roll-ups, which acquire practices as add-ons to scale a larger group. Strategic acquirers and health systems buy to expand geography or specialties. Many deals are structured through a management services organization (MSO) that owns the non-clinical operations while licensed providers retain the clinical entity.
- Why are healthcare deals structured through an MSO?
- In many states, corporate practice of medicine doctrines restrict non-physician or corporate ownership of clinical practices. An MSO or "friendly PC" model separates the management company from the clinical entity so investors can own the business side while providers own the practice. This is general background, not legal advice; consult healthcare counsel, as rules vary by state and subsector.
- How long does it take to sell a healthcare-services business?
- A prepared lower-middle-market process typically runs about six to twelve months: roughly one to two months of preparation and quality-of-earnings work, a few months of buyer outreach and offers, then eight to sixteen weeks of diligence and legal documentation. Regulatory, licensure, or payor consents can extend the timeline, so early preparation is the biggest driver of a faster close.
Considering a sale in the next few years? See what a prepared process looks like.
Keep reading